B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)

BRIEF

published on 07/29/2026 at 14:24, 3 months 8 days ago

BRAIN Biotech AG Names Dr. Sven K. Weber as CEO

CEO Appointment Executive Board Leadership Change BRAIN Biotech Dr. Sven K. Weber
PRESS RELEASE

published on 07/29/2026 at 14:19, 3 months 8 days ago

EQS-Adhoc: BRAIN Biotech AG Appoints Dr. Sven K. Weber as New Chairman of the Executive Board, Effective October 1, 2026
BRAIN Biotech AG appoints Dr. Sven K. Weber as new Chairman of the Executive Board, effective October 1, 2026. Dr. Weber, with experience at BASF SE, replaces Adriaan Moelker

Executive Board Chairman Appointment Management Change BRAIN Biotech AG Dr. Sven K. Weber
BRIEF

published on 07/13/2026 at 13:04, 3 months 24 days ago

BRAIN Biotech AG Secures New Revolving Credit Facility

BRAIN Biotech AG Corporate Financing Interest Rate Revolving Credit Facility MP Beteiligungs-GmbH
PRESS RELEASE

published on 07/13/2026 at 12:59, 3 months 24 days ago

EQS-Adhoc: BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH
BRAIN Biotech AG signs new €9.0 million Revolving Credit Facility with MP Beteiligungs-GmbH for general corporate financing purposes and debt services

BRAIN Biotech AG Corporate Financing Revolving Credit Facility MP Beteiligungs-GmbH Debt Services
BRIEF

published on 05/28/2026 at 07:35, 5 months 9 days ago

BRAIN Biotech AG Releases H1 Financials and Maintains Full-Year Forecast

Revenue Decline Half-year Results BRAIN Biotech AG BioSolutions Genome Editing
PRESS RELEASE

published on 05/28/2026 at 07:30, 5 months 9 days ago

BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26, with sequential growth in core segment BRAINBiocatalysts and a new European patent for genome editing. Full year guidance confirmed

Financial Forecast Half-year Results BRAIN Biotech AG EU Patent Genome Editing
BRIEF

published on 03/23/2026 at 11:10, 7 months 14 days ago

BRAIN Biotech Secures Patent for CRISPR-BMC Technology

BRAIN Biotech Genome-editing CRISPR-BMC Patent Granted Licensing Potential
PRESS RELEASE

published on 03/23/2026 at 11:05, 7 months 14 days ago

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
BRAIN Biotech secures key patent for CRISPR-BMC genome-editing technology, opening potential for commercial use through licensing. Nuclease exhibits high activity in various organisms

Patent BRAIN Biotech Licensing CRISPR-BMC Genome-editing Technology
BRIEF

published on 03/11/2026 at 17:10, 7 months 26 days ago

BRAIN Biotech AG 2026 AGM Results

Annual General Meeting Supervisory Board BRAINBiocatalysts Two-pillar Strategy Enzyme Production
PRESS RELEASE

published on 03/11/2026 at 17:05, 7 months 26 days ago

Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG. Shareholders approve all agenda items. New member elected to the Supervisory Board. CEO highlights company's strategy and unique selling points

Annual General Meeting Financial Year Supervisory Board BRAIN Biotech AG Product Innovations

Published on 11/06/2026 at 13:00, 7 hours 39 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 8 hours 9 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 8 hours 9 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 10 hours 39 minutes ago

Mongolia Tax Audit
Published on 11/06/2026 at 05:15, 15 hours 24 minutes ago

Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins

View all ACCESSWIRE

Published on 11/06/2026 at 20:15, 24 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 1 hour 24 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 hour 39 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 2 hours 7 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 2 hours 39 minutes ago

ARVERNE GROUP: Number shares and voting rights

View all EQS

Published on 11/06/2026 at 18:00, 2 hours 39 minutes ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 2 hours 39 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 2 hours 45 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 3 hours 4 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 9 hours 34 minutes ago

voting rights

View all LES ECHOS COMFI WIRE

News